Pharmacological properties agonist H1 histamine receptors and blood vessels of the inner ear antagonist NZ- histamine receptors of the vestibular nuclei of the central nervous system.According to preclinical studies by relaxing the sphincter prekapilyarnyh vessels of the inner ear improves blood circulation in the inner ear vascular ledge. Dose-dependently reduced the generation of action potentials in the neurons of the lateral and medial vestibular nuclei. It accelerates the recovery of vestibular function after unilateral vestibular neyrektomii, accelerating and facilitating central vestibular compensation (due to antagonism with the NC-histamine receptors). It eases symptoms of the syndrome of Meniere and vertigo.
When taken orally dianabol steroid rapidly and almost completely absorbed in the gastrointestinal tract. After absorption of the drug is rapidly and almost completely metabolised to form inactive metabolite 2-pyridylacetic acid.
Before the drug at a dose of about 8-48 mg of 85% of the initial dose is found in the urine as a 2-pyridylacetic acid. Elimination of dianabol steroid kidneys or via the gut slightly. Elimination rate constant remains dianabol steroid after oral administration 8-48 mg, ukazshaya dianabol steroid pharmacokinetic linearity, and suggests that the metabolic pathway involved remains unsaturated. When taken with food preparation dianabol steroid maximum concentration is lower than in the fasting state. However, the total absorption of dianabol steroid same in both cases, indicating that ingestion of only slows down the absorption of dianabol steroid.
Ménière’s syndrome, characterized by the following main symptoms:
- dizziness (accompanied by nausea / vomiting)
- hearing loss (deafness)
- noise in ears
Symptomatic treatment of vestibular vertigo (vertigo).
- hypersensitivity to any component of the drug.
Betaserk ® is not recommended for use in children under the age of 18 years due to lack of efficacy and safety data.
Application of pregnancy and during breastfeeding
The available data on the use of dianabol steroid in pregnant women is not enough.
The potential risk for humans is unknown. The use of dianabol steroid during pregnancy is permitted if the benefits from the use of the mother outweighs the potential risk to the fetus.
It is not known whether dianabol steroid is excreted in breast milk. Do not take the medication during breastfeeding. The appointment of a medicinal drug to the mother should be taken only after a comparison of the benefits of breastfeeding to the potential risk to the infant.
in the treatment of patients with gastric ulcer and 12 duodenal ulcer history. Patients with pheochromocytoma and asthma during treatment should be monitored regularly by a doctor.
Dosing and Administration
Always take Betaserk ® exactly as your doctor has prescribed. If you have any questions, consult your doctor.
Inside, during a meal.
Dose for adults is 48 mg per day of dianabol steroid.
Betaserk ® 24 mg should take 1 tablet 2 times a day. The tablet can be divided into two equal parts, as shown in Fig.
Place the tablet on a hard surface and push the notch up his thumb on it.
The dose should be individualized depending on the response to treatment. The improvement sometimes seen in just a few weeks of treatment. The best results are obtained sometimes after several months of treatment. There is evidence that the appointment of treatment early in the disease to prevent its progression and / or hearing loss in later stages. Correction of the dose in elderly patients and in patients with renal and / or hepatic impairment is not required.
If you notice any side effects not listed in this manual, or any side effect has taken serious, report, please your doctor.
Gastrointestinal disorders: Most (by> 1/100 to <1/10): nausea and dyspepsia. In addition to these effects identified in clinical trials, during post-marketing use and in scientific literature reported the following adverse effects. Available data are insufficient to estimate their frequency.
Immune system: hypersensitivity reactions, including anaphylaxis reported.
From the gastrointestinal tract: moderate disorders, such as vomiting, pain in the gastrointestinal tract, bloating. Typically, these effects usually disappear after dosing with food or after a dose reduction.
Skin and subcutaneous tissue: Hypersensitivity reactions such as angioneurotic edema, urticaria, pruritus and rash.
Several cases of overdose. Some patients experienced light to moderate symptoms (nausea, drowsiness, abdominal pain) after taking the drug at doses up to 640 mg. More serious complications (spasm, cardiopulmonary complications) were observed at higher doses deliberate dianabol steroid, especially in combination with other drugs overdose. Recommended symptomatic treatment.
Interaction with other medicines
If you are currently or in the recent past, you are taking other medicines, including those without a doctor’s prescription, report it, please your doctor. Studies in vivo, aimed at studying the interactions with other drugs have not been conducted. These in vitro studies suggest no activity inhibiting cytochrome P450 isozymes in vivo.
Effects on ability to drive car and other machines.
It is believed that the effect of betagietina on ability to drive and other mechanisms is absent or negligible, as in clinical trials involving the use of betagietina, effects, potentially influencing this ability were found.
Tablets 24 mg: 20 tablets in PVC / PVDC / Al blister, 1, 2, 3 or 5 blisters together with instructions for use in a cardboard box. On 25 tablets in PVC / PVDC / Al blister, 1, 2 or 4 blisters with instruction for use in a cardboard box. tumor marker does hcg increase testosterone injections weight loss results
protein a antibody complementos nutricionales para deportistas proteina c reactiva